Novartis India Limited
NSE: NOVARTIND | Information Technology
Market Fundamentals
Stock Intelligence & News
Novartis’ experimental prostate cancer drug shows promise
Novartis’ experimental prostate cancer drug shows promise
Read Full Analysis →Experimental Novartis radiopharma drug shows promise in early study
Experimental Novartis radiopharma drug shows promise in early study
Read Full Analysis →Generics drugmaker Sandoz calls for EU to probe alleged China dumping
Novartis spin-off says Chinese overcapacity threatens European self-reliance and access to key antibiotic
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Novartis AG (NVS) Expands U.S. Manufacturing Footprint with New Texas Site
Novartis AG (NVS) Expands U.S. Manufacturing Footprint with New Texas Site
Read Full Analysis →Novartis’ Q1 sales miss hints at industry’s utilisation of M&A remedies
Novartis’ Q1 sales miss hints at industry’s utilisation of M&A remedies
Read Full Analysis →Novartis Dips As Generics Take A Bite Out Of Its First-Quarter Sales
Novartis Dips As Generics Take A Bite Out Of Its First-Quarter Sales
Read Full Analysis →Novartis Earnings Hit by Generic Competition
Novartis Earnings Hit by Generic Competition
Read Full Analysis →Novartis Q1 profit misses expectations as sales fall on generic headwinds
Novartis Q1 profit misses expectations as sales fall on generic headwinds
Read Full Analysis →Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology.
Read Full Analysis →Novartis AG (NVS): One of the Best Low Risk High Growth Plays on the Market
Novartis AG (NVS): One of the Best Low Risk High Growth Plays on the Market
Read Full Analysis →Get instant alerts when NOVARTIND breaks news
Join investors who track Novartis India Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for NOVARTIND?
NOVARTIND is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Novartis India Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding NOVARTIND to your custom watchlist.